M&A Deal Summary

PLIVA HRVATSKA d.o.o. Acquires Odyssey Pharmaceuticals

On July 17, 2002, PLIVA HRVATSKA d.o.o. acquired life science company Odyssey Pharmaceuticals

Acquisition Highlights
  • This is PLIVA HRVATSKA d.o.o.’s 3rd transaction in the Life Science sector.
  • This is PLIVA HRVATSKA d.o.o.’s 2nd transaction in the United States.
  • This is PLIVA HRVATSKA d.o.o.’s 2nd transaction in New Jersey.

M&A Deal Summary

Date 2002-07-17
Target Odyssey Pharmaceuticals
Sector Life Science
Buyer(s) PLIVA HRVATSKA d.o.o.
Deal Type Add-on Acquisition

Target

Odyssey Pharmaceuticals

East Hanover, New Jersey, United States
Odyssey Pharmaceuticals, Inc. engages in the acquisition, development, and marketing of niche branded pharmaceutical products.

Search 177,829 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PLIVA HRVATSKA d.o.o.

Zagreb, Croatia

website


Category Company
Sector Life Science
DESCRIPTION

PLIVA HRVATSKA d.o.o. is a production portfolio includes a high number of finished dosage forms covering almost all therapeutic groups and active pharmaceutical ingredients. The company is focused on development of generic and niche products.


DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 3 of 3
State (New Jersey) 2 of 2
Country (United States) 2 of 2
Year (2002) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-07-17 Sidmak Laboratories

East Hanover, New Jersey, United States

Sidmak Laboratories, Inc. is a pharmaceutical company engages in the development, manufacture, and marketing of generic pharmaceutical products and active pharmaceutical ingredients.

Buy -